Artelo Biosciences
ARTL
ARTL
1 hedge funds and large institutions have $38K invested in Artelo Biosciences in 2019 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
1
Holders Change
-2
Holders Change %
-66.67%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$0 |
| 2 |
2
Goldman Sachs
New York
|
$38K |
| 3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Goldman Sachs
New York
| $38K | 14,223 | -1,401 | -9% |
|
|
2
UBS Group
Zurich,
Switzerland
| – | – | -3,630 | Closed |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| – | – | -253 | Closed |
|
|
CFGS
4
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|